Wei-Xiang Qi, MD, RT

Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai

Disclosures:

  • Employment: none
  • Compensation: :Role Topic Description-End Date:
  • Ownership: none
  • Leadership: none

Presentations

Sep 28

129 - Sequential Chemo-Immunotherapy plus Optimized Thoracic Radiotherapy vs. Standard Thoracic Radiotherapy for Elderly and/ or Frail Stage III Non-Small-Cell Lung Cancer: A Randomized Open-Label Controlled Trial of iLCC-3
Room 156/158
02:50pm - 03:00pm PT
Sep 29

3167 - INHBA is a Key Mediator of Proton Radiotherapy in Reversing Photon-Induced Radioresistance in Breast Cancer
Hall F
05:00pm - 06:00pm PT
Sep 30

3509 - Association of Skeletal Muscle and Adiposity Measured by Computed Tomography with Toxicity and pCR in Esophageal Squamous Cell Carcinoma Receiving Standardized Neoadjuvant Chemoradiotherapy
Hall F
02:30pm - 03:45pm PT
Sep 30

3561 - The Predictive Value of Pretreatment Peripheral T-Lymphocyte Subsets for Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma Patients Undergoing Neoadjuvant Chemoradiotherapy: A Prospective Cohort Analysis
Hall F
02:30pm - 03:45pm PT